How to buy Acorda Therapeutics shares

Acorda Therapeutics shares have increased 0.77% from yesterday's closing price ($15.3). Learn how to easily invest in Acorda Therapeutics shares in the UK.

Acorda Therapeutics Inc (ACOR) is a publicly traded drug manufacturers-specialty and generic business based in the US. On 13 September Acorda Therapeutics shares leapt 10.90% to a closing position of $14.86. However, over the last 12 months, Acorda Therapeutics's share price has fallen by 8.57% from $5.72 (accounting for the 5 June 2023 split). Acorda Therapeutics is listed on the NASDAQ and employs 111 staff. All prices are listed in US Dollars.

How to buy shares in Acorda Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ACOR in this case.
  5. Research Acorda Therapeutics shares. The platform should provide the latest information available.
  6. Buy your Acorda Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy Acorda Therapeutics shares:

Best for

Beginner investments

IG Share Dealing image

Fees for buying 100x Acorda Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Customer rating Platform fee Min. initial deposit Trading fee estimate
Freetrade logo ★★★★★ £0 - £9.99 No minimum £2.53
£430.97 total
Capital at risk
eToro Free Stocks logo ★★★★★ £0 $50 £2.14
£430.58 total
Capital at risk
IG Share Dealing logo ★★★★★ £0 £250 £10.38
£438.82 total
Capital at risk
XTB logo Not yet rated £0 No minimum £2.14
£430.58 total
Capital at risk
CMC Invest share dealing account logo Not yet rated £0 No minimum £2.14
£430.58 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo ★★★★★ £0 £1 £16.23
£444.68 total
Capital at risk
Lightyear logo Not yet rated £0 No minimum £1.58
£430.02 total
Capital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in Acorda Therapeutics

Is it a good time to buy Acorda Therapeutics stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks

Invest in Acorda Therapeutics shares
Finder Award

  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Acorda Therapeutics under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Acorda Therapeutics P/E ratio, PEG ratio and EBITDA

Acorda Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Acorda Therapeutics shares trade at around 2x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Acorda Therapeutics's P/E ratio is best considered in relation to those of others within the drug manufacturers-specialty & generic industry or those of similar companies.

    Acorda Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.51. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.

    The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Acorda Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

    However, it's sensible to consider Acorda Therapeutics's PEG ratio in relation to those of similar companies.

      Acorda Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.5 million (£0.0 million).

      The EBITDA is a measure of a Acorda Therapeutics's overall financial performance and is widely used to measure a its profitability.

      To put that into context you can compare it against similar companies.

      Frequently asked questions

      All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

      More guides on Finder

      • How to buy Exelixis shares

        Ever wondered how to buy shares in Exelixis? We explain how and compare a range of providers that can give you access to many brands, including Exelixis.

      • How to buy Five Star Senior Living shares

        Ever wondered how to buy shares in Five Star Senior Living? We explain how and compare a range of providers that can give you access to many brands, including Five Star Senior Living.

      • How to buy Community Health Systems shares

        Ever wondered how to buy shares in Community Health Systems? We explain how and compare a range of providers that can give you access to many brands, including Community Health Systems.

      • How to buy Chiasma shares

        Ever wondered how to buy shares in Chiasma? We explain how and compare a range of providers that can give you access to many brands, including Chiasma.

      • How to buy Healthcare Services Group shares

        Ever wondered how to buy shares in Healthcare Services Group? We explain how and compare a range of providers that can give you access to many brands, including Healthcare Services Group.

      • How to buy Catalent shares

        Ever wondered how to buy shares in Catalent? We explain how and compare a range of providers that can give you access to many brands, including Catalent.

      • How to buy Aytu BioScience shares

        Ever wondered how to buy shares in Aytu BioScience? We explain how and compare a range of providers that can give you access to many brands, including Aytu BioScience.

      • How to buy bluebird bio shares

        Ever wondered how to buy shares in bluebird bio? We explain how and compare a range of providers that can give you access to many brands, including bluebird bio.

      • How to buy LHC Group shares

        Ever wondered how to buy shares in LHC Group? We explain how and compare a range of providers that can give you access to many brands, including LHC Group.

      • How to buy Amneal Pharmaceuticals shares

        Ever wondered how to buy shares in Amneal Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Amneal Pharmaceuticals.

      Go to site